Lariam

The proposed class-action case brought last year by an Army veteran accused Roche Laboratories Inc. and Genentech Inc. of intentionally misleading the Department of Defense and the Food and Drug Administration about the dangers of mefloquine, the generic version of the drug Lariam.

Roche, which was granted the intellectual property rights and won FDA approval for Lariam in 1989, said it manufactured its last lots for U.S. distribution in 2005.

On a trip to Panama some years ago, my roommate developed psychotic hallucinations from the drug Lariam, which the Centers for Disease Control and Prevention had recommended at the time to prevent malaria.

Defense attorneys contended that Bales likely used Lariam while on a 2003-2004 tour in Iraq, and possibly in Afghanistan in 2012.

But the three-judge panel said that defense affidavits to support their case that Bales used Lariam were speculative.